Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 13:00 ET | Source: AlphaTON Capital

Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries

London, UK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Brittany Kaiser, CEO of AlphaTON Capital (Nasdaq: ATON) and global data-rights activist, will speak on a high-profile panel at SALT London 2025, taking...
November 03, 2025 08:00 ET | Source: AlphaTON Capital

AlphaTON Capital Takes Center Stage at TRUST Summit 2025 to Shape the Future of Digital Finance

New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON) today announced that CEO Brittany Kaiser and senior leadership will join global policymakers and institutional...
November 03, 2025 08:00 ET | Source: AlphaTON Capital

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (Nasdaq: ATON), a specialized digital asset treasury company focused on the Telegram...
October 29, 2025 10:46 ET | Source: AlphaTON Capital

AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network

Dubai, UAE, Oct. 29, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (Nasdaq: ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosystem, today announced...
October 27, 2025 08:10 ET | Source: AlphaTON Capital

AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025

Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and...
October 27, 2025 08:00 ET | Source: AlphaTON Capital

AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026

Dover, DE, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics...
October 25, 2025 12:30 ET | Source: AlphaTON Capital

AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing

Dover, DE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today...
October 24, 2025 08:05 ET | Source: AlphaTON Capital

AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer

New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (NASDAQ: ATON) (“AlphaTON” or the “Company”), a specialized digital asset treasury company building the TON ecosystem, today...
October 22, 2025 12:45 ET | Source: AlphaTON Capital

AlphaTON Capital Joins Blockchain Game Alliance (BGA)

Geneva, Switzerland , Oct. 22, 2025 (GLOBE NEWSWIRE) -- “1 Billion Players. One Tap to Play.” AlphaTON backs gaming where distribution already lives—inside Telegram—pairing funding, launch support,...
October 22, 2025 12:00 ET | Source: AlphaTON Capital

AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth

Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the...